[ Price : $8.95]
FDA considers industry and advertiser proposals to allow links to risk information for promotional activities on character space-l...[ Price : $8.95]
Federal Register Notice: FDA asks for comments on an OMB submission seeking an information collection extension on the use of focu...[ Price : $8.95]
Federal Register Notice: FDA establishes a public docket to receive input on a CDRH new program on Patient and Care-partner Connec...[ Price : $8.95]
Federal Register Notice: FDA makes available a guidance on Clinical Considerations for Investigational Device Exemptions (IDEs) fo...[ Price : $8.95]
FDA posts a guidance on Non-Inferiority Clinical Trials to Establish Effectiveness that discusses the appropriate use of such stud...[ Price : $8.95]
FDA clears an EOS Imaging 510(k) to market the kneeEOS software, an online 3D planning product software that uses weight-bearing 3...[ Price : $8.95]
FDA approves an Amgen supplemental BLA for the expanded use of Enbrel (etanercept) to treat pediatric patients (ages 4-17) with ch...[ Price : $8.95]
FDA commissioner Robert Califf and CMS administrator Andrew Slavitt offer their perspectives on the two agencies changing approach...